Meta-analyses reveal serum or plasma Interleukin-6 as a biomarker for malignant ovarian neoplasia-Reference-Cited by-同舟云学术

Meta-analyses reveal serum or plasma Interleukin-6 as a biomarker for malignant ovarian neoplasia

Published:2023-01 Issue: Volume:161 Page:156073
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Pașca Andrei,Fischer-Fodor Eva,Monica Jiboc Nicoleta,Milan Kubelac Paul,Saha Bhaskar,Vlad Cătălin,Andrei Achimaș-Cadariu Patriciu

Funder

Romania Ministry of Research and Innovation

Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii

Corporation for National and Community Service

Ministerul Cercetării şi Inovării

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference71 articles.

1. Definition of rare cancer - NCI Dictionary of Cancer Terms - National Cancer Institute, (2011). https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rare-cancer (accessed the 9th of February, 2022).

2. Cancer of the Ovary - Cancer Stat Facts, SEER. (n.d.). https://seer.cancer.gov/statfacts/html/ovary.html (accessed the 9th of February, 2022).

3. 25-Ovary-fact-sheet.pdf, (n.d.). https://gco.iarc.fr/today/data/factsheets/cancers/25-Ovary-fact-sheet.pdf (accessed February 9, 2022).

4. Cancer statistics, 2018 - Siegel - 2018 - CA: A Cancer Journal for Clinicians - Wiley Online Library, (n.d.). https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21442 (accessed the 9th of February, 2022).

5. Epithelial ovarian cancer: Evolution of management in the era of precision medicine;Lheureux;CA Cancer J. Clin.,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin-6 serves as a critical factor in various cancer progression and therapy;Medical Oncology;2024-06-20

2. Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis;Journal of Translational Medicine;2024-04-30

3. The potential role of interleukins and interferons in ovarian cancer;Cytokine;2023-11